Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.
Leukemia
; 31(11): 2435-2442, 2017 11.
Article
in En
| MEDLINE
| ID: mdl-28373701
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido